Pfizer Buys Seagen

1 year ago
176

Pfizer has struck a $43 billion deal to acquire Seagen and its targeted cancer drugs. The company is thus preparing for a sharp drop in sales of its Covid-19 treatment.

Seagen is Pfizer's largest acquisition in a string of recent acquisitions using cash proceeds from the vaccine and Covid-19 treatment. It will add four approved cancer drugs with combined sales of about $2 billion in 2022.

Loading 3 comments...